Diet, physical exercise and Orlistat administration increase serum Anti-Mullerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)

被引:32
|
作者
Vosnakis, Christos [1 ]
Georgopoulos, Neoklis A. [2 ]
Rousso, David [1 ]
Mavromatidis, Georgios [1 ]
Katsikis, Ilias [3 ]
Roupas, Nikolaos D. [2 ]
Mamali, Irene [2 ]
Panidis, Dimitrios [3 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 3, GR-54006 Thessaloniki, Greece
[2] Univ Patras, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, Patras 26500, Greece
[3] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 2, Div Endocrinol & Human Reprod, GR-54006 Thessaloniki, Greece
关键词
Anti-Mullerian Hormone; LH; insulin resistance; Orlistat; PCOS; INHIBITING SUBSTANCE LEVELS; LUTEINIZING-HORMONE; INSULIN-RESISTANCE; MOUSE OVARY; LEAN WOMEN; OBESITY; GROWTH; ASSOCIATION; GHRELIN; FSH;
D O I
10.3109/09513590.2012.736557
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study investigates the combined effect of diet, physical exercise and Orlistat for 24 weeks, on serum Anti-Mullerian Hormone (AMH) levels in overweight and obese women with polycystic ovary syndrome (PCOS) and in overweight and obese controls. Sixty-one (61) selected women with PCOS and 20 overweight and obese controls followed an energy-restricted diet, physical exercise plus Orlistat administration (120 mg, 3 times per day) for 24 weeks. At baseline, week 12 and week 24, serum levels of AMH, FSH, LH, PRL, androgens, sex hormone-binding globulin (SHBG), glucose, and insulin were measured and Free Androgen Index (FAI) and Insulin Resistance (IR) indices were calculated. In PCOS women, serum AMH levels increased after 12 and 24 weeks of treatment. After 12 weeks LH and SHBG were increased, while Testosterone decreased. After 12 and 24 weeks, FAI was decreased and all indices of IR were significantly improved. We concluded that in overweight and obese women with PCOS Orlistat administration, combined with diet and physical exercise, for 24 weeks, resulted in significant weight loss, improvement of hyperandrogenism and insulin sensitivity, and increased serum AMH levels.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 50 条
  • [21] Anti-Mullerian hormone (AMH) as a useful marker in diagnosis of polycystic ovary syndrome
    Leonte, Laura
    Coculescu, M.
    Radian, S.
    Fica, Simona
    Caragheorgheopol, Andra
    Marinescu, B.
    Bohaltea, L. C.
    Grigorescu, F.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2007, 3 (01) : 1 - 11
  • [22] Clinical utility of Serum anti-Mullerian hormone in Polycystic Ovarian syndrome (PCOS) women
    Cheluvaraju, Rohitha
    Mahey, Reeta
    Malhotra, Neena
    Rajput, Monika
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 130 : 207 - 207
  • [23] Clinical utility of Serum anti-Mullerian hormone in Polycystic Ovarian syndrome (PCOS) women
    Cheluvaraju, Rohitha
    Mahey, Reeta
    Malhotra, Neena
    Rajput, Monika
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 130 : 207 - 207
  • [24] CHARACTERIZATION OF WOMEN WITH ULTRA HIGH SERUM ANTI-MULLERIAN HORMONE (AMH) LEVELS AND ITS ASSOCIATION WITH POLYCYSTIC OVARIAN SYNDROME (PCOS) PHENOTYPE.
    Tal, R.
    Seder, D. B.
    Khanimov, M.
    Grazi, R. V.
    Leader, B.
    FERTILITY AND STERILITY, 2013, 100 (03) : S127 - S127
  • [25] The relationship between serum anti-Mullerian hormone levels and the follicular arrest for women with polycystic ovary syndrome
    Li, Jian
    Li, Rong
    Yu, Hua
    Zhao, Shuyun
    Yu, Yang
    Qiao, Jie
    SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2015, 61 (02) : 103 - 109
  • [26] Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome
    Wong, Ho Yan Queenie
    Li, Hang Wun Raymond
    Lam, Karen Siu Ling
    Tam, Sidney
    Shek, Chi Chung
    Lee, Chi Yan Vivian
    Yeung, William Shu Biu
    Ho, Pak Chung
    Ng, Ernest Hung Yu
    CLINICAL ENDOCRINOLOGY, 2018, 89 (05) : 634 - 641
  • [27] Anti-Mullerian hormone and polycystic ovary syndrome
    Lebkowska, Agnieszka
    Kowalska, Irina
    ENDOKRYNOLOGIA POLSKA, 2017, 68 (01) : 74 - 78
  • [28] Anti-Mullerian hormone and polycystic ovary syndrome
    Catteau-Jonard, S.
    Dewailly, D.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2011, 39 (09): : 514 - 517
  • [29] CAN ANTI-MULLERIAN HORMONE (AMH) LEVELS PREDICT RESPONSE TO OVULATION INDUCTION TREATMENTS IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME (PCOS)?
    Vagios, Stylianos
    Sacha, Caitlin R.
    Hsu, Jennifer Y.
    Dimitriadis, Irene
    Bormann, Charles L.
    James, Kaitlyn E.
    Souter, Irene
    FERTILITY AND STERILITY, 2019, 112 (03) : E391 - E392
  • [30] Health Behavior Associated with Anti-Mullerian Hormone (AMH) Relationship in Women with Polycystic Ovary (PCO) Syndrome
    Atlihan, Ufuk
    Derundere, Umit
    AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2023, 47 (05): : 1015 - 1022